Bausch Health (BHC) Expands Probiotic Skincare Bet To Six New Markets
On September 8, Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Paulson & Co John Paulson | 73,255,869 | $361,151,434 | 14.02% | |
| 2. | GoldenTree Asset Management Steven Tananbaum | 34,665,731 | $170,706,865 | 9.92% | |
| 3. | MFN Partners Farhad Nanji And Michael Demichele | 6,000,000 | $29,580,000 | 0.61% | |
| 4. | Hudson Bay Capital Management Sander Gerber | 5,000,000 | $24,650,000 | 0.07% | |
| 5. | Tontine Asset Management Jeffrey Gendell | 4,037,091 | $19,902,859 | +36% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.25 | 2,500,000 | $15,625,000.00 | 73,255,869 | 2025-11-25 | Filing | |
| $9.00 | 34,721,118 | $312,490,062.00 | 70,755,869 | 2025-08-14 | Filing | |
| $7.06 | 86,409 | $610,047.54 | 36,034,751 | 2025-08-13 | Filing | |
| $6.88 | 1,156,640 | $7,957,683.20 | 35,948,342 | 2025-08-12 | Filing | |
| $6.35 | 2,000,000 | $12,700,000.00 | 34,791,702 | 2025-08-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.03 | 36,827 | $258,893.81 | 334,853 | 2026-08-19 | Filing | |
| $5.43 | 24,456 | $132,796.08 | 49,339 | 2026-05-19 | Filing | |
| $5.77 | 4,420 | $25,503.40 | 616,761 | 2026-03-03 | Filing | |
| $5.78 | 6,856 | $39,627.68 | 776,076 | 2026-03-02 | Filing | |
| $5.95 | 8,388 | $49,908.60 | 809,258 | 2026-02-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,832,582 | $53,404,000 | 0.01% | |
| 2. | 8,000,000 | $39,440,000 | 0.06% | |
| 3. | 7,465,468 | $36,797,292 | 0% | |
| 4. | 4,803,485 | $33,169,671 | 0% | |
| 5. | 6,225,131 | $30,689,896 | 0% |
News See All
Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook
Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set the ground for the company’s profit recovery.
Blowing Past the Street: 46 Stocks That Crushed Q2 EPS Projections
More than 250 companies announced their earnings performance in the second quarter of the year on Wednesday, July 29, offering a fresh look at how they performed relative to what the market expected of...
15 Best NYSE Penny Stocks to Buy According to Hedge Funds
In this article, we will take a look at some of the best penny stocks listed on the New York Stock Exchange that are currently being highly favored by hedge funds.
Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript April 29, 2026Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.78 EPS, expectations were $0.81.
Billionaire Howard Marks' 10 Stock Picks with Huge Upside Potential
In this article, we discuss the Billionaire Howard Marks' 10 Stock Picks with Huge Upside Potential.
7 Best Small-Cap Drug Manufacturing Stocks to Buy According to Hedge Funds
In this article, we will take a look at some of the small-cap drug manufacturing stocks that are highly favored by hedge funds.
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
Bausch Health Companies Inc. (NYSE:BHC) is among the 7 Oversold Pharma Stocks to Buy Now. Bausch Health Companies Inc. (NYSE:BHC) is one of the most oversold stocks.
7 Oversold Pharma Stocks to Buy Now
In this article, we will be taking a look at the 7 Oversold Pharma Stocks to Buy Now.
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript February 18, 2026Bausch Health Companies Inc. misses on earnings expectations.
Hedge Fund Resource Center